Theranostic Pairing: ABY-025/251 Targeting HER2 with 68ga and 188re—minimized Radioligands Using Affibody Peptide Scaffold Technology.
Journal of Clinical Oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2022)